PSEPX
Price
$19.31
Change
+$0.10 (+0.52%)
Updated
Jul 3 closing price
Net Assets
32.11M
VVIAX
Price
$70.10
Change
+$0.40 (+0.57%)
Updated
Jul 3 closing price
Net Assets
188.77B
Interact to see
Advertisement

PSEPX vs VVIAX

Header iconPSEPX vs VVIAX Comparison
Open Charts PSEPX vs VVIAXBanner chart's image
1789 Growth and Income P
Price$19.31
Change+$0.10 (+0.52%)
VolumeN/A
Net Assets32.11M
Vanguard Value Index Adm
Price$70.10
Change+$0.40 (+0.57%)
VolumeN/A
Net Assets188.77B
PSEPX vs VVIAX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
PSEPX vs. VVIAX commentary
Jul 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is PSEPX is a Buy and VVIAX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
VVIAX has more cash in the bank: 189B vs. PSEPX (32.1M). VVIAX pays higher dividends than PSEPX: VVIAX (2.18) vs PSEPX (1.13). PSEPX was incepted earlier than VVIAX: PSEPX (12 years) vs VVIAX (25 years). PSEPX (1.03) is less costly to investors than VVIAX (0.05). PSEPX is a more actively managed with annual turnover of: 20.00 vs. VVIAX (9.00). PSEPX has a lower initial minimum investment than VVIAX: PSEPX (2000) vs VVIAX (3000). PSEPX annual gain was more profitable for investors over the last year : 13.79 vs. VVIAX (12.03). VVIAX return over 5 years is better than : 80.13 vs. PSEPX (62.37).
PSEPXVVIAXPSEPX / VVIAX
Total Expense Ratio1.030.052,060%
Annual Report Gross Expense Ratio1.030.052,060%
Fund Existence12 years25 years-
Gain YTD6.4966.198105%
Front LoadN/AN/A-
Min. Initial Investment2000300067%
Min. Initial Investment IRAN/AN/A-
Net Assets32.1M189B0%
Annual Yield % from dividends1.132.1852%
Returns for 1 year13.7912.03115%
Returns for 3 years28.9535.1782%
Returns for 5 years62.3780.1378%
Returns for 10 years74.07115.6764%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CAVA86.523.81
+4.61%
CAVA Group
ADTN9.560.16
+1.70%
ADTRAN Holdings
TWST38.170.49
+1.30%
Twist Bioscience Corp
ATMC11.84N/A
N/A
AlphaTime Acquisition Corp
SCNI2.20-0.07
-2.95%
Scinai Immunotherapeutics Ltd.